Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Seasonal allergic rhinitis patients out of pollen season~* Have a history and presence of birch and/or timothy grass pollen induced seasonal allergic rhinitis for at least the previous 2 years (verified by a positive skin prick test)~* Patients with need of treatment for their nasal symptoms during the pollen season~Exclusion Criteria:~* Symptomatic perennial allergic or non-allergic rhinitis~* Family history of autoimmune disease A history of asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- 1. AZD8848 (Type: EXPERIMENTAL): 20 μg AZD8848 three times weekly
- 2. Placebo (Type: PLACEBO_COMPARATOR): Placebo three times weekly
- 3. AZD8848 and placebo (Type: EXPERIMENTAL): 60 μg AZD8848 once weekly and placebo twice weekly

Based on this trial design, predict the completion outcome and termination type (if applicable).